Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1012059-50-5

Post Buying Request

1012059-50-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1012059-50-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1012059-50-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,2,0,5 and 9 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1012059-50:
(9*1)+(8*0)+(7*1)+(6*2)+(5*0)+(4*5)+(3*9)+(2*5)+(1*0)=85
85 % 10 = 5
So 1012059-50-5 is a valid CAS Registry Number.

1012059-50-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-amino-1-[(4-methoxyphenyl)methyl]-3H-imidazo[4,5-c]pyridine-2-thione

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1012059-50-5 SDS

1012059-50-5Relevant articles and documents

Fused Amino Pyridines for the Treatment of Lung Cancer

-

, (2016/11/17)

The present invention relates to the use of compounds with fused amino pyridine core for the treatment of malignancies associated with brain and lung. The oral administration of compounds of the instant application results in effective brain penetration and provides for non-intrusive treatment of brain and lung tumors.

HSP90 Inhibitors Containing a Zinc Binding Moiety

-

Page/Page column 35; 43, (2008/12/08)

The present invention relates to HSP90 inhibitors and their use in the treatment of cell proliferative diseases such as cancer. The said derivatives may further act as HDAC inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1012059-50-5